Photodynamic Therapy treatment of onychomycosis with Aluminium-Phthalocyanine Chloride nanoemulsions: A proof of concept clinical trial

Journal of Photochemistry and Photobiology B: Biology

Volumn 173, Issue , 2017, Pages 266-270

  Morgado, Luciano Ferreira ^a   Trávolo, Ana Regina Franchi ^a   Muehlmann, Luís Alexandre ^a   Narcizo, Paulo Souza ^a   Nunes, Rodrigo Barbosa ^a   Pereira, Pedro Alencar Gomes ^a   Py Daniel, Karen Rapp ^a   Jiang, Cheng Shi ^b   Gu, Jinsong ^a   Azevedo, Ricardo Bentes ^a   Longo, João Paulo Figueiró ^a  

^a UNIVERSITY OF BRASILIA   (Brazil)

^b UNIVERSITY OF JINAN   (China)

Author keywords

Nanoemulsion; Onychomycosis; Photodynamic Therapy

Indexed keywords

DRUG CARRIER; PHTHALOCYANINE ALUMINUM; ALUMINUM; EMULSION; INDOLE DERIVATIVE; NANOMATERIAL; PHOTOSENSITIZING AGENT; PHTHALOCYANINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; FEMALE; FUNGUS CULTURE; HUMAN; LIGHT EMITTING DIODE; MALE; NANOEMULSION; NANOMEDICINE; ONYCHOMYCOSIS; PATIENT SAFETY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; VISUAL ANALOG SCALE; ADVERSE EFFECTS; CHEMISTRY; EMULSION; MIDDLE AGED; PHOTOCHEMOTHERAPY; PROCEDURES; TREATMENT OUTCOME;

ALUMINUM; EMULSIONS; FEMALE; HUMANS; INDOLES; MALE; MIDDLE AGED; NANOSTRUCTURES; ONYCHOMYCOSIS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; TREATMENT OUTCOME;

EID: 85020706822     PISSN: 10111344     EISSN: 18732682     Source Type: Journal    
DOI: 10.1016/j.jphotobiol.2017.06.010     Document Type: Article

References (22)

1. [1] Scher, R.K., Tavakkol, A., Sigurgeirsson, B., Hay, R.J., Joseph, W.S., Tosti, A., Fleckman, P., Ghannoum, M., Armstrong, D.G., Markinson, B.C., Onychomycosis: diagnosis and definition of cure. J. Am. Acad. Dermatol. 56:6 (2007), 939–944.
2. [2] Scher, R.K., Onychomycosis: a significant medical disorder. J. Am. Acad. Dermatol. 35:3 (1996), S2–S5.
3. [3] Ghannoum, M., Hajjeh, R., Scher, R., Konnikov, N., Gupta, A., Summerbell, R., Sullivan, S., Daniel, R., Krusinski, P., Fleckman, P., A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns. J. Am. Acad. Dermatol. 43:4 (2000), 641–648.
4. [4] Hay, R., The future of onychomycosis therapy may involve a combination of approaches. Br. J. Dermatol. 145:S60 (2001), 3–8.
5. [5] da Silva, A.P., Chiandrone, D.J., Tinta, J.W.R., Kurachi, C., Inada, N.M., Bagnato, V.S., Development and comparison of two devices for treatment of onychomycosis by photodynamic therapy. J. Biomed. Opt., 20(6), 2015, 061109.
6. [6] Sotiriou, E., Koussidou-Ermonti, T., Chaidemenos, G., Apalla, Z., Ioannides, D., Photodynamic therapy for distal and lateral subungual toenail onychomycosis caused by Trichophyton rubrum: preliminary results of a single-centre open trial. Acta Derm. Venereol. 90:2 (2010), 216–217.
7. [7] da Silva, A.P., Kurachi, C., Bagnato, V.S., Inada, N.M., Fast elimination of onychomycosis by hematoporphyrin derivative-photodynamic therapy. Photodiagn. Photodyn. Ther. 10:3 (2013), 328–330.
8. [8] Figueiredo Souza, L., Souza, S., Botelho, A., Randomized controlled trial comparing photodynamic therapy based on methylene blue dye and fluconazole for toenail onychomycosis. Dermatol. Ther. 27:1 (2014), 43–47.
9. [9] Senge, M.O., mTHPC–a drug on its way from second to third generation photosensitizer?. Photodiagn. Photodyn. Ther. 9:2 (2012), 170–179.
10. [10] Muehlmann, L.A., Rodrigues, M.C., Longo, J.P.F., Garcia, M.P., Py-Daniel, K.R., Veloso, A.B., de Souza, P.E.N., da Silva, S.W., Azevedo, R.B., Aluminium-phthalocyanine chloride nanoemulsions for anticancer photodynamic therapy: development and in vitro activity against monolayers and spheroids of human mammary adenocarcinoma MCF-7 cells. J. Nanobiotechnol., 13(1), 2015, 36.
11. [11] Mang, T.S., Dosimetric concepts for PDT. Photodiagn. Photodyn. Ther. 5:3 (2008), 217–223.
12. [12] Souza, L.W.F., Souza, S.V.T., Botelho, A.C.d.C., Distal and lateral toenail onychomycosis caused by Trichophyton rubrum: treatment with photodynamic therapy based on methylene blue dye. An. Bras. Dermatol. 89:1 (2014), 184–186.
13. [13] Kim, J.E., Park, H.J., Lee, J.Y., Cho, B.K., The compliance and long-term follow up of onychomycosis treatment. Korean J. Med. Mycol. 8:3 (2003), 110–117.
14. [14] da Silva, A.P., Carbinatto, F.M., Bagnato, V.S., Inada, N.M., A promising strategy for the treatment of onychomycosis with curcumin and photodynamic therapy. J. Pharm. Pharmacol. 3 (2015), 434–437.
15. [15] Gilaberte, Y., Robres, M., Frías, M., García-Doval, I., Rezusta, A., Aspiroz, C., Methyl aminolevulinate photodynamic therapy for onychomycosis: a multicentre, randomized, controlled clinical trial. J. Eur. Acad. Dermatol. Venereol. 31:2 (2016), 347–354.
16. [16] Simmons, B., Griffith, R., Falto-Aizpurua, L., Nouri, K., An update on photodynamic therapies in the treatment of onychomycosis. J. Eur. Acad. Dermatol. Venereol. 29:7 (2015), 1275–1279.
17. [17] Muehlmann, L.A., Joanitti, G.A., Silva, J.R., Longo, J.P.F., Azevedo, R.B., Liposomal photosensitizers: potential platforms for anticancer photodynamic therapy. Braz. J. Med. Biol. Res. 44:8 (2011), 729–737.
18. [18] Qiao, J., Li, R., Ding, Y., Fang, H., Photodynamic therapy in the treatment of superficial mycoses: an evidence-based evaluation. Mycopathologia 170:5 (2010), 339–343.
19. [19] Mahtab, A., Anwar, M., Mallick, N., Naz, Z., Jain, G.K., Ahmad, F.J., Transungual delivery of ketoconazole nanoemulgel for the effective management of onychomycosis. AAPS PharmSciTech, 2016, 1–14.
20. [20] Longo, J.P.F., Leal, S.C., Simioni, A.R., Menezes Almeida-Santos, M.d.F., Tedesco, A.C., Azevedo, R.B., Photodynamic therapy disinfection of carious tissue mediated by aluminum-chloride-phthalocyanine entrapped in cationic liposomes: an in vitro and clinical study. Lasers Med. Sci. 27:3 (2012), 575–584.
21. [21] Elewski, B., Onychomycosis treatment, quality of life, and economic issues. Am. J. Clin. Dermatol. 1:1 (1999), 19–26.
22. [22] Piraccini, B.M., Sisti, A., Tosti, A., Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents. J. Am. Acad. Dermatol. 62:3 (2010), 411–414.